Major threat to malaria control programs by plasmodium falciparum lacking histidine-rich protein 2, Eritrea

Emerging Infectious Diseases

Volumn 24, Issue 3, 2018, Pages 462-470

  Berhane, Araia ^a   Anderson, Karen ^b,c   Mihreteab, Selam ^a   Gresty, Karryn ^b,c   Rogier, Eric ^d   Mohamed, Salih ^a   Hagos, Filmon ^a   Embaye, Ghirmay ^a   Chinorumba, Anderson ^e   Zehaie, Assefash ^e   Dowd, Simone ^b   Waters, Norman C ^f   Gatton, Michelle L ^g   Udhayakumar, Venkatachalam ^d   Cheng, Qin ^b,c   Cunningham, Jane ^e  

^a Ministry of Health   (Eritrea)

^b Australian Defence Force Malaria and Infectious Disease Institute   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^g QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE RICH PROTEIN 2; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; HRP3 PROTEIN, PLASMODIUM FALCIPARUM; MICROSATELLITE DNA; PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DNA FLANKING REGION; FEMALE; GENE DELETION; GENETIC DISTANCE; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALE; MICROSATELLITE MARKER; MICROSCOPY; NONHUMAN; PARASITE LOAD; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; ERITREA; GENETIC VARIATION; GENETICS; GENOTYPE; GEOGRAPHY; HEALTH SURVEY; MALARIA FALCIPARUM; MIDDLE AGED; PARASITOLOGY; PUBLIC HEALTH; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, PROTOZOAN; CHILD; ERITREA; GENE DELETION; GENETIC VARIATION; GENOTYPE; GEOGRAPHY; HUMANS; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PLASMODIUM FALCIPARUM; POPULATION SURVEILLANCE; PROTOZOAN PROTEINS; YOUNG ADULT;

EID: 85042266098     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2403.171723     Document Type: Article

References (30)

1. Nyarango PM, Gebremeskel T, Mebrahtu G, Mufunda J, Abdulmumini U, Ogbamariam A, et al. A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods. Malar J. 2006;5:33. http://dx.doi.org/10.1186/1475-2875-5-33
2. Barat LM. Four malaria success stories: how malaria burden was successfully reduced in Brazil, Eritrea, India, and Vietnam. Am J Trop Med Hyg. 2006;74:12–6.
3. World Health Organization. World malaria report 2016 [cited 2017 Nov 29]. http://www.who.int/malaria/publications/world-malaria-report-2016/report/en/
4. Berhane A. Changing pettern of P. vivax malaria in Eritrea: implication for the national malaria control. Journal of the Eritrean Medical Association. 2011;1:17–20.
5. World Health Organization. WHO Global Malaria Programme Information note on recommended selection criteria for procurement of malaria rapid diagnostic tests (RDTs), 2012 [cited 2017 Nov 29]. http://www.who.int/malaria/publications/atoz/rdt-selection-criteria.pdf
6. Berhane A, Russom M, Bahta I, Hagos F, Ghirmai M, Uqubay S. Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results. Malar J. 2017;16:105. http://dx.doi.org/10.1186/s12936-017-1752-9
7. Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One. 2010;5:e8091. http://dx.doi.org/10.1371/journal.pone.0008091
8. Murillo Solano C, Akinyi Okoth S, Abdallah JF, Pava Z, Dorado E, Incardona S, et al. Deletion of Plasmodium falciparum histidine-rich protein 2 (pfhrp2) and histidine-rich protein 3 (pfhrp3) genes in Colombian parasites. PLoS One. 2015;10:e0131576. http://dx.doi.org/10.1371/journal.pone.0131576
9. Akinyi Okoth S, Abdallah JF, Ceron N, Adhin MR, Chandrabose J, Krishnalall K, et al. Variation in Plasmodium falciparum histidine-rich protein 2 (pfhrp2) and Plasmodium falciparum histidine-rich protein 3 (pfhrp3) gene deletions in Guyana and Suriname. PLoS One. 2015;10:e0126805. http://dx.doi.org/10.1371/journal.pone.0126805
10. Rachid Viana GM, Akinyi Okoth S, Silva-Flannery L, Lima Barbosa DR, Macedo de Oliveira A, Goldman IF, et al. Histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in Plasmodium falciparum isolates from select sites in Brazil and Bolivia. PLoS One. 2017;12:e0171150. http://dx.doi.org/10.1371/journal.pone.0171150
11. Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, et al. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions. PLoS One. 2012;7:e43094. http://dx.doi.org/10.1371/journal.pone.0043094
12. Bharti PK, Chandel HS, Ahmad A, Krishna S, Udhayakumar V, Singh N. Prevalence of pfhrp2 and/or pfhrp3 gene deletion in Plasmodium falciparum population in eight highly endemic states in India. PLoS One. 2016;11:e0157949. http://dx.doi.org/10.1371/journal.pone.0157949
13. Li P, Xing H, Zhao Z, Yang Z, Cao Y, Li W, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 in the China–Myanmar border area. Acta Trop. 2015;152:26–31. http://dx.doi.org/10.1016/j.actatropica.2015.08.003
14. Koita OA, Doumbo OK, Ouattara A, Tall LK, Konaré A, Diakité M, et al. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg. 2012;86:194–8. http://dx.doi.org/10.4269/ajtmh.2012.10-0665
15. Wurtz N, Fall B, Bui K, Pascual A, Fall M, Camara C, et al. Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J. 2013;12:34. http://dx.doi.org/10.1186/1475-2875-12-34
16. Parr JB, Verity R, Doctor SM, Janko M, Carey-Ewend K, Turman BJ, et al. Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of Congo: a national cross-sectional survey. J Infect Dis. 2017;216:36–44.
17. Amoah LE, Abankwa J, Oppong A. Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: based malaria rapid diagnostic tests in Ghana. Malar J. 2016;15:101. http://dx.doi.org/10.1186/s12936-016-1159-z
18. Gatton ML, Dunn J, Chaudhry A, Ciketic S, Cunningham J, Cheng Q. Implications of parasites lacking Plasmodium falciparum histidine-rich protein 2 on malaria morbidity and control when rapid diagnostic tests are used for diagnosis. J Infect Dis. 2017;215:1156–66. http://dx.doi.org/10.1093/infdis/jix094
19. World Health Organization Western Pacific Region. Malaria microscopy standard operating procedures, 2016 [cited 2017 Nov 29]. http://www.wpro.who.int/mvp/lab_quality/mm_sop/en/
20. Padley D, Moody AH, Chiodini PL, Saldanha J. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol. 2003;97:131–7. http://dx.doi.org/10.1179/000349803125002977
21. Cheng Q, Gatton ML, Barnwell J, Chiodini P, McCarthy J, Bell D, et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J. 2014;13:283. http://dx.doi.org/10.1186/1475-2875-13-283
22. Rogier E, Plucinski M, Lucchi N, Mace K, Chang M, Lemoine JF, et al. Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests. PLoS One. 2017;12:e0172139. http://dx.doi.org/10.1371/journal.pone.0172139
23. Akinyi S, Hayden T, Gamboa D, Torres K, Bendezu J, Abdallah JF, et al. Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Sci Rep. 2013;3:2797. http://dx.doi.org/10.1038/srep02797
24. Ribeiro-Gonçalves B, Francisco AP, Vaz C, Ramirez M, Carriço JA. PHYLOViZ Online: web-based tool for visualization, phylogenetic inference, analysis and sharing of minimum spanning trees. Nucleic Acids Res. 2016;44(W1):W246–51. http://dx.doi.org/10.1093/nar/gkw359
25. Incardona S, Serra-Casas E, Champouillon N, Nsanzabana C, Cunningham J, González IJ. Global survey of malaria rapid diagnostic test (RDT) sales, procurement and lot verification practices: assessing the use of the WHO–FIND Malaria RDT Evaluation Programme (2011–2014). Malar J. 2017;16:196. http://dx.doi.org/10.1186/s12936-017-1850-8
26. World Health Organization. Malaria rapid diagnostic test performance: summary results of WHO product testing of malaria RDTs: round 1–7 (2008–2016), 2017 [cited 2017 Nov 29] http://www.who.int/malaria/publications/atoz/978924151268/en/
27. World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions, 2016 [cited 2017 Nov 29] http://www.who.int/malaria/publications/atoz/information-note-hrp2-based-rdt/en/
28. Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis. 2005;192:870–7. http://dx.doi.org/10.1086/432010
29. World Health Organization. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 7 (2015–2016), 2017 [cited 2017 Nov 29]. http://www.who.int/malaria/publications/atoz/978924151268
30. World Health Organization. Determining whether histidine rich protein gene deletions causing negative HRP2 RDT results among symptomatic falciparum patients have reached a threshold for switching malaria RDTs, 2017 [cited 2017 Nov 29]. http://www.who.int/malaria/areas/diagnosis/en/